Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
The current price of Moderna Inc in the market is 404,43 kr., with a 24-hour trading volume of 1,58B kr.. The asset's market cap is 160,47B kr., after moving -2.11% in the last day.
Tokenized Moderna Inc is trading at 401,02 kr., with a tokenized market cap of 373,88K kr. and a 24-hour trading volume of 3,92M kr.. The tokenized asset has moved -2.17% in the past 24 hours.